Trioctanoin and its metabolite, 2-EHA, were applied on fresh human abdominal skin for up to 24 hours. Franz-type diffusion static cells were used as in vitro model. Receptor liquid was sampled at 3, 6 and 24 hours for the quantification of 2-EHA and Trioctanoin. Analyses of both compounds by LC-MS/MS were performed in skin washing, stratum corneum strips, epidermis, dermis and receptor compartment washing.
After topical application of Trioctanoin on fresh dermatomed human skin pre-treated or not with a dermaroller, 2-EHA concentrations in receptor liquid were under the lower limit of quantification (LLOQ). Therefore, no biotransformation of Trioctanoin in 2-EHA occurred in the condition of the incubation.
This study supports the conclusion that:
- 2-EHA applied on fresh human abdominal skin is able to pass through the skin.
- The skin, particularly the dermis is able to metabolize Trioctanoin into 2-EHA.
- Trioctanoin does not pass through the skin; it is stopped by the stratum corneum so there is no 2-EHA formation, even if the skin is slightly irritated.
- Trioctanoin can be safely used as an ingredient in cosmetic products.